Titan Medical (TMDIF) Competitors $0.30 0.00 (-0.13%) As of 05/19/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesSEC FilingsTrendsBuy This Stock TMDIF vs. OBIO, ICAD, MGRM, GUTS, MBOT, EDAP, FONR, SRTS, NSPR, and MLSSShould you be buying Titan Medical stock or one of its competitors? The main competitors of Titan Medical include Orchestra BioMed (OBIO), iCAD (ICAD), Monogram Orthopaedics (MGRM), Fractyl Health (GUTS), Microbot Medical (MBOT), Edap Tms (EDAP), FONAR (FONR), Sensus Healthcare (SRTS), InspireMD (NSPR), and Milestone Scientific (MLSS). These companies are all part of the "medical equipment" industry. Titan Medical vs. Orchestra BioMed iCAD Monogram Orthopaedics Fractyl Health Microbot Medical Edap Tms FONAR Sensus Healthcare InspireMD Milestone Scientific Titan Medical (NASDAQ:TMDIF) and Orchestra BioMed (NASDAQ:OBIO) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, earnings, community ranking, media sentiment, analyst recommendations, risk, dividends, institutional ownership and profitability. Do institutionals and insiders believe in TMDIF or OBIO? 0.0% of Titan Medical shares are owned by institutional investors. Comparatively, 53.5% of Orchestra BioMed shares are owned by institutional investors. 0.0% of Titan Medical shares are owned by insiders. Comparatively, 8.1% of Orchestra BioMed shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has better earnings and valuation, TMDIF or OBIO? Titan Medical has higher revenue and earnings than Orchestra BioMed. Orchestra BioMed is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTitan Medical$17.63M1.97$6.95M$0.056.10Orchestra BioMed$2.89M38.25-$49.12M-$1.78-1.62 Does the media refer more to TMDIF or OBIO? In the previous week, Orchestra BioMed had 5 more articles in the media than Titan Medical. MarketBeat recorded 5 mentions for Orchestra BioMed and 0 mentions for Titan Medical. Orchestra BioMed's average media sentiment score of 0.43 beat Titan Medical's score of 0.00 indicating that Orchestra BioMed is being referred to more favorably in the news media. Company Overall Sentiment Titan Medical Neutral Orchestra BioMed Neutral Which has more volatility and risk, TMDIF or OBIO? Titan Medical has a beta of 1.26, suggesting that its share price is 26% more volatile than the S&P 500. Comparatively, Orchestra BioMed has a beta of 0.67, suggesting that its share price is 33% less volatile than the S&P 500. Does the MarketBeat Community prefer TMDIF or OBIO? Orchestra BioMed received 21 more outperform votes than Titan Medical when rated by MarketBeat users. CompanyUnderperformOutperformTitan MedicalN/AN/AOrchestra BioMedOutperform Votes21100.00% Underperform VotesNo Votes Is TMDIF or OBIO more profitable? Titan Medical has a net margin of 0.00% compared to Orchestra BioMed's net margin of -2,179.33%. Titan Medical's return on equity of -82.31% beat Orchestra BioMed's return on equity.Company Net Margins Return on Equity Return on Assets Titan MedicalN/A -82.31% -51.47% Orchestra BioMed -2,179.33%-107.04%-70.88% Do analysts prefer TMDIF or OBIO? Orchestra BioMed has a consensus target price of $14.20, suggesting a potential upside of 392.88%. Given Orchestra BioMed's stronger consensus rating and higher probable upside, analysts plainly believe Orchestra BioMed is more favorable than Titan Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Titan Medical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Orchestra BioMed 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 3.20 SummaryOrchestra BioMed beats Titan Medical on 10 of the 18 factors compared between the two stocks. Get Titan Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for TMDIF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TMDIF vs. The Competition Export to ExcelMetricTitan MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$34.78M$4.54B$5.42B$8.48BDividend YieldN/A43.65%5.22%4.11%P/E Ratio-0.2429.8726.7820.05Price / Sales1.9770.45395.49116.44Price / Cash0.0251.0838.2534.62Price / Book0.296.346.874.61Net Income$6.95M$67.64M$3.22B$248.19M7 Day Performance18.20%21.94%5.69%2.56%1 Month Performance-14.69%26.54%12.66%16.18%1 Year PerformanceN/A22.75%18.01%8.16% Titan Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TMDIFTitan MedicalN/A$0.31-0.1%N/A+771.4%$34.78M$17.63M-0.2450OBIOOrchestra BioMed2.8577 of 5 stars$2.94+10.9%$14.20+383.0%-43.6%$112.64M$2.64M-1.834ICADiCAD0.4719 of 5 stars$3.93+5.9%N/A+141.5%$107.86M$19.61M-30.23140News CoverageAnalyst ForecastHigh Trading VolumeMGRMMonogram Orthopaedics3.1447 of 5 stars$2.59-1.5%$5.40+108.5%+40.1%$91.40M$364,999.00-5.5128Earnings ReportGUTSFractyl Health1.7382 of 5 stars$1.77+3.5%$11.00+521.5%-69.9%$86.69M$93,000.00-0.15102MBOTMicrobot Medical1.9468 of 5 stars$2.38-6.7%$9.00+278.2%+162.1%$82.69MN/A-2.9720Positive NewsEarnings ReportGap UpEDAPEdap Tms1.8608 of 5 stars$2.18+1.4%$8.50+289.9%-69.5%$80.89M$64.12M-3.35230Earnings ReportAnalyst RevisionFONRFONAR1.8185 of 5 stars$12.32-0.4%N/A-1.8%$76.52M$101.57M10.71480News CoverageEarnings ReportAnalyst UpgradeSRTSSensus Healthcare2.7618 of 5 stars$4.59+0.9%$13.00+183.2%-23.3%$75.71M$41.81M11.4840News CoverageEarnings ReportAnalyst ForecastAnalyst RevisionNSPRInspireMD2.2804 of 5 stars$2.43-5.8%$4.50+85.2%-3.9%$74.44M$7.01M-3.2450MLSSMilestone Scientific0.5825 of 5 stars$0.91-1.6%$1.25+37.4%+46.9%$71.33M$8.63M-13.0030Analyst Forecast Related Companies and Tools Related Companies Orchestra BioMed Alternatives iCAD Alternatives Monogram Orthopaedics Alternatives Fractyl Health Alternatives Microbot Medical Alternatives Edap Tms Alternatives FONAR Alternatives Sensus Healthcare Alternatives InspireMD Alternatives Milestone Scientific Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TMDIF) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Titan Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Titan Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
